AMGEN INC (AMGN)
Clinical trial NCT07366086 updates: 1. completion date: 2028-05-21 → 2028-04-19 2. primary completion date: 2028-05-21 → 2028-04-19
Clinical trial NCT07366086 updates: 1. completion date: 2028-05-21 → 2028-04-19 2. primary completion date: 2028-05-21 → 2028-04-19
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical